Aktie - SCR | ADVFN

Professionelle Tools für Privatanleger.

Premium

Current Price

9,60

Gebot

Fragen

Volumen

0,00

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

9,60

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

SCOR publishes a net income of EUR 512 million along with a 15% increase in shareholders' equity, and proposes a dividend of ...

2014 Annual Results SCOR publishes a net income of EUR 512 million along with a 15% increase in shareholders' equity, and proposes a dividend of EUR 1.40, up 8% ...

SCOR Global Life supports Sun Life in the first longevity insurance transaction in Canada

PARIS, March 3, 2015 (GLOBE NEWSWIRE) -- Press Release 3 March 2015 - N°04 SCOR Global Life supports Sun Life in the first longevity insurance transaction in Canada...

January 2015 Renewals: SCOR Global P&C delivers premium growth of 2.4%, while maintaining expected profitability

PARIS, Feb. 10, 2015 (GLOBE NEWSWIRE) -- Contacts Marie-Laurence Bouchon Group Head of Communications +33 (0)1 58 44 76 10 mbouchon@scor.com Bertrand Bougon Head of Investor...

SCOR delivers a strong performance for the first half 2014 with net income of EUR 256 million, up 35% from H1 2013

Paris, France, July 31, 2014 (GLOBE NEWSWIRE) -- Press Release ...

SCOR delivers a strong performance for the first quarter 2014 with a net income of EUR 135 million, up 21.6%

PARIS, May 6, 2014 (GLOBE NEWSWIRE) -- Press Release ...

SCOR posts record net income of EUR 549 million and an ROE of 11.5% in 2013, and proposes a dividend of EUR 1.30 per share[1]...

PARIS, March 5, 2014 (GLOBE NEWSWIRE) -- For more information, please contact: Géraldine Fontaine ...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

SCR - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is US$ 9,60

What is the 1 year trading range for share price?

has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
MBIMBIA Inc	US$ 7,11 (15,42%)	2,37M
ALURAllurion Technologies Inc	US$ 6,07 (13,46%)	571,74k
SESSES AI Corporation	US$ 1,19 (13,33%)	24,78M
ENFYEnlightify Inc	US$ 1,36 (12,40%)	95,69k
LITBLightInTheBox Holding Co Ltd	US$ 1,155 (12,14%)	17,51k
DECKDeckers Outdoor	US$ 177,46 (-20,46%)	15,04M
BZHBeazer Homes USA Inc New	US$ 22,18 (-19,93%)	2,11M
VSTSVestis Corporation	US$ 14,00 (-11,62%)	6,16M
KOREKORE Group Holdings Inc	US$ 2,29 (-9,13%)	36,39k
NOVASunnova Energy International Inc	US$ 2,565 (-9,04%)	14,63M
FFord Motor Company	US$ 10,08 (-0,79%)	103,99M
QBTSD Wave Quantum Inc	US$ 5,94 (5,32%)	75,07M
BBDBanco Bradesco SA	US$ 2,12 (0,47%)	55,89M
NUNu Holdings Ltd	US$ 13,25 (-1,41%)	48,21M
VZVerizon Communications Inc	US$ 39,39 (-0,20%)	45,19M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares (SCR)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

SCR Neueste Nachrichten

SCOR publishes a net income of EUR 512 million along with a 15% increase in shareholders' equity, and proposes a dividend of ...

SCOR Global Life supports Sun Life in the first longevity insurance transaction in Canada

January 2015 Renewals: SCOR Global P&C delivers premium growth of 2.4%, while maintaining expected profitability

SCOR delivers a strong performance for the first half 2014 with net income of EUR 256 million, up 35% from H1 2013

SCOR delivers a strong performance for the first quarter 2014 with a net income of EUR 135 million, up 21.6%

SCOR posts record net income of EUR 549 million and an ROE of 11.5% in 2013, and proposes a dividend of EUR 1.30 per share[1]...

SCOR Global P&C delivers strong January renewals with 5% premium growth and stable expected net technical profitability

Simcere Pharmaceutical Group Announces Completion of Merger

Simcere Pharmaceutical Group Announces Shareholders' Approval of the Merger Agreement

Simcere Pharmaceutical Group Provides Notice of Annual General Meeting

SCR - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares (SCR) Börsenkurse

Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares (SCR)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

SCR Neueste Nachrichten

SCR - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE